Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
| Image |  |
|---|---|
| Description | scientific article published on 7 March 2013 |
| Author/s |
author: Konstanze Döhner Hartmut Döhner |
| Publication date | March 7, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |